Literature DB >> 17846390

Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons.

Rik P Bogers1, Wanda J E Bemelmans, Rudolf T Hoogenveen, Hendriek C Boshuizen, Mark Woodward, Paul Knekt, Rob M van Dam, Frank B Hu, Tommy L S Visscher, Alessandro Menotti, Roland J Thorpe, Konrad Jamrozik, Susanna Calling, Bjørn Heine Strand, Martin J Shipley.   

Abstract

BACKGROUND: The extent to which moderate overweight (body mass index [BMI], 25.0-29.9 [calculated as weight in kilograms divided by height in meters squared]) and obesity (BMI, >/= 30.0) are associated with increased risk of coronary heart disease (CHD) through adverse effects on blood pressure and cholesterol levels is unclear, as is the risk of CHD that remains after these mediating effects are considered.
METHODS: Relative risks (RRs) of CHD associated with moderate overweight and obesity with and without adjustment for blood pressure and cholesterol concentrations were calculated by the members of a collaboration of prospective cohort studies of healthy, mainly white persons and pooled by means of random-effects models (RRs for categories of BMI in 14 cohorts and for continuous BMI in 21 cohorts; total N = 302 296).
RESULTS: A total of 18 000 CHD events occurred during follow-up. The age-, sex-, physical activity-, and smoking-adjusted RRs (95% confidence intervals) for moderate overweight and obesity compared with normal weight were 1.32 (1.24-1.40) and 1.81 (1.56-2.10), respectively. Additional adjustment for blood pressure and cholesterol levels reduced the RR to 1.17 (1.11-1.23) for moderate overweight and to 1.49 (1.32-1.67) for obesity. The RR associated with a 5-unit BMI increment was 1.29 (1.22-1.35) before and 1.16 (1.11-1.21) after adjustment for blood pressure and cholesterol levels.
CONCLUSIONS: Adverse effects of overweight on blood pressure and cholesterol levels could account for about 45% of the increased risk of CHD. Even for moderate overweight, there is a significant increased risk of CHD independent of these traditional risk factors, although confounding (eg, by dietary factors) cannot be completely ruled out.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17846390     DOI: 10.1001/archinte.167.16.1720

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  180 in total

1.  Impact of exercise and dietary fatty acid composition from a high-fat diet on markers of hunger and satiety.

Authors:  J A Cooper; A C Watras; C M Paton; F H Wegner; A K Adams; D A Schoeller
Journal:  Appetite       Date:  2010-10-28       Impact factor: 3.868

2.  Cardiovascular Consequences of Obesity and Targets for Treatment.

Authors:  Bettina Mittendorfer; Linda R Peterson
Journal:  Drug Discov Today Ther Strateg       Date:  2008

3.  Tennis training sessions as a rehabilitation instrument for patients after acute myocardial infarction.

Authors:  Juan P F García; Víctor M A Giraldo; José J G Barrado; César D Casasola
Journal:  J Sports Sci Med       Date:  2013-06-01       Impact factor: 2.988

Review 4.  Do differences in risk factors explain the lower rates of coronary heart disease in Japanese versus U.S. women?

Authors:  Akira Sekikawa; Bradley J Willcox; Takeshi Usui; John Jeffrey Carr; Emma J M Barinas-Mitchell; Kamal H Masaki; Makoto Watanabe; Russell P Tracy; Marianne H Bertolet; Rhobert W Evans; Kunihiko Nishimura; Kim Sutton-Tyrrell; Lewis H Kuller; Yoshihiro Miyamoto
Journal:  J Womens Health (Larchmt)       Date:  2013-09-28       Impact factor: 2.681

5.  Obesity among patients with HIV: the latest epidemic.

Authors:  Nancy Crum-Cianflone; Raechel Tejidor; Sheila Medina; Irma Barahona; Anuradha Ganesan
Journal:  AIDS Patient Care STDS       Date:  2008-12       Impact factor: 5.078

Review 6.  Efficacy and tolerability of GLP-1 agonists in patients with type 2 diabetes mellitus: an Indian perspective.

Authors:  Mala Dharmalingam
Journal:  Ther Adv Endocrinol Metab       Date:  2014-12       Impact factor: 3.565

7.  Fatty acid-binding protein 4 and incident heart failure: the Cardiovascular Health Study.

Authors:  Luc Djoussé; Traci M Bartz; Joachim H Ix; Jinesh Kochar; Jorge R Kizer; John S Gottdiener; Russell P Tracy; Dariush Mozaffarian; David S Siscovick; Kenneth J Mukamal; Susan J Zieman
Journal:  Eur J Heart Fail       Date:  2012-12-06       Impact factor: 15.534

8.  [Epidemiology of obesity].

Authors:  R Gellner; W Domschke
Journal:  Chirurg       Date:  2008-09       Impact factor: 0.955

Review 9.  Benefit-risk paradigm for clinical trial design of obesity devices: FDA proposal.

Authors:  Herbert Lerner; Joyce Whang; Rebecca Nipper
Journal:  Surg Endosc       Date:  2012-12-18       Impact factor: 4.584

10.  Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients.

Authors:  K Eeg-Olofsson; J Cederholm; P M Nilsson; B Zethelius; L Nunez; S Gudbjörnsdóttir; B Eliasson
Journal:  Diabetologia       Date:  2008-11-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.